ATXN2 and amyotrophic lateral sclerosis: Consequently, analysis of polyglutamine length of Atx2 in ALS patients led to the conclusion that the presence of an intermediate length glutamine expansion (27-33Q) was associated with an increased risk of ALS, a conclusion that was matched by the early age of onset in affected individuals 29.